These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37139651)

  • 1. Complexities of rifamycin use in persons with HIV infection.
    Nguyen NN; Winslow DL
    AIDS; 2023 Jun; 37(7):1161-1163. PubMed ID: 37139651
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.
    Rabie H; Decloedt EH; Garcia-Prats AJ; Cotton MF; Frigati L; Lallemant M; Hesseling A; Schaaf HS
    Expert Opin Pharmacother; 2017 Apr; 18(6):589-598. PubMed ID: 28346018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients.
    Singh R; Marshall N; Smith CJ; Reynolds CJ; Breen RA; Bhagani S; Cropley I; Hopkins S; Swaden L; Johnson MA; Lipman MC
    AIDS; 2013 Jan; 27(3):481-4. PubMed ID: 23014518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of tuberculosis in HIV-1-infected adults treated after rifamycin-based treatment and highly active antiretroviral therapy.
    Hung CC; Hsiao CF
    J Acquir Immune Defic Syndr; 2003 Dec; 34(4):437-9. PubMed ID: 14615663
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.
    Nettles RE; Mazo D; Alwood K; Gachuhi R; Maltas G; Wendel K; Cronin W; Hooper N; Bishai W; Sterling TR
    Clin Infect Dis; 2004 Mar; 38(5):731-6. PubMed ID: 14986259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.
    Regazzi M; Carvalho AC; Villani P; Matteelli A
    Clin Pharmacokinet; 2014 Jun; 53(6):489-507. PubMed ID: 24777631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why the treatment with Reprimun could be efficient for tuberculosis prevention in HIV infected individuals.
    Păunescu E
    Pneumoftiziologia; 1992; 41(1):45-6. PubMed ID: 1299399
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
    Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
    J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.
    TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile.
    Huang JS; Jiang ZD; Garey KW; Lasco T; Dupont HL
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2690-3. PubMed ID: 23545528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis.
    Marchesoni A; Sinigaglia L; Ranza R; Varenna M; Battafarano N; Tosi S
    Scand J Rheumatol; 1993; 22(4):194-8. PubMed ID: 8356413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prosthetic penile infection: "rescue procedure" with rifamycin.
    Teloken C; Souto JC; Da Ros C; Thorel E; Souto CA
    J Urol; 1992 Dec; 148(6):1905-6. PubMed ID: 1433637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis and HIV co-infection: a practical therapeutic approach.
    Breen RA; Swaden L; Ballinger J; Lipman MC
    Drugs; 2006; 66(18):2299-308. PubMed ID: 17181373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial.
    Singh P; Moulton LH; Barnes GL; Gupta A; Msandiwa R; Chaisson RE; Martinson NA
    J Acquir Immune Defic Syndr; 2022 Dec; 91(4):397-402. PubMed ID: 36000934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV.
    Caruso I; Montrone F; Fumagalli M; Patrono C; Santandrea S; Gandini MC
    Ann Rheum Dis; 1982 Jun; 41(3):232-6. PubMed ID: 7046652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea.
    Garey KW; Salazar M; Shah D; Rodrigue R; DuPont HL
    Ann Pharmacother; 2008 Jun; 42(6):827-35. PubMed ID: 18430792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in the clinical use of rifamycin SV].
    Govorovich EA; Marshak AM; Iakovlev VP
    Antibiotiki; 1972 Nov; 17(11):1022-5. PubMed ID: 4664262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.